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1. Introduction 
There is now considerable evidence that hormone- 
receptor interactions activate adenylate cyclase and 
the resulting increases in cyclic AMP levels mediate 
the effects of the hormone [ 1 ] . However, a study 
of corticotrophin (ACTH) stimulation of cyclic 
AMP production and steroidogenesis in isolated 
adrenal cells has suggested that cyclic AMP is not 
involved in the stimulation of steroidogenesis by 
small amounts of ACTH [2]. Similarly, human 
chorionic gonadotrophin (hCG)-stimulated testos- 
terone production in dispersed interstitial cells 
appears to be independent of changes in cyclic AMP 
levels [3]. Scranton and Tong [4] have reported 
that thyrotrophin (TSH) causes a rapid stimulation 
of iodine release from isolated thyroid cells in the 
absence of stimulation of iodine uptake and in this 
paper. We describe a study of the relationship 
between TSH stimulation of iodine release, intra- 
cellular cyclic AMP levels and TSH receptor binding 
using isolated porcine thyroid cells. Since sera from 
patients with Graves’ disease contain antibody 
molecules which mimic the effects of TSH by inter- 
acting with the TSH receptor [S] , the effects of 
these Graves’ immunoglobulins on the isolated thyroid 
cells have also been studied. 
2. Methods 
2.1. Thyroid cell isok tion and culture 
Porcine thyroid cells were isolated by trypsinisa- 
tion of finely chopped tissue [6 ] and cultured on plastic 
North-Holland Publishing Company - Amsterdam 
supports in the presence of 0.4 mM dibutyryl cyclic 
AMP for 48 or 72 h [7]. During this period the cells 
formed 3dimensional follicular structures which 
were capable of iodine organification [8]. Cells were 
removed from the plastic support after the culture 
period treatment with 3 mM EGTA [9]. The cells 
were washed and resuspended in minimal essential 
medium containing 10% foetal calf serum and 20 mM 
Hepes pH 7.4 (Medium I-I). Cell viability was deter- 
mined using trypan blue dye exclusion [IO] and 
found to be about 80%. 
2.2. Ehyrotrophin receptor binding 
Highly purified bovine TSH (30 units/mg, generous 
gifts from Dr J. G. Pierce and Dr J. Fawcett) was 
labelled with 12’1 to a specific activity of 160 pCi/ 
E.cg and receptor purified using human thyroid 
membranes [ 111. Studies with a highly sensitive 
cytochemical bioassay [12] indicated that the 1251- 
labelled hormone showed identical biological activity 
to the unlabelled TSH. Harvested cells (2 X IO6 in 
0.25 ml of Medium H) were added to 0.25 ml of 
Medium H containing 15 000 cpm (60 pg) of labelled 
TSH, 10 nM KI and varying doses of unlabelled 
bovine TSH (1 unit/mg, a generous gift from the 
Armour Pharmaceutical Company, UK). After 
incubation at 37°C in a shaking water bath (150 cycles/ 
minute) the reaction mixtures were diluted with 
2.5 ml of ice cold Medium H and centrifuged for 
1 min at 1500 X g. The supernatants were aspirated, 
the cell pellet washed once by resuspension in 2.5 ml 
of Medium H followed by re-centrifugation and the 
amount of “‘1 in the pellet measured. All determina- 
tions were made in triplicate. 
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2.3. ~ti~~~ff~o~ of 1251 release from the i~lated Table 1 
thyroid cells 
Suspensions of harvested cells (4 X 106/ml) were 
incubated with Na’251 (0.4 @/lo6 cells) for 20 min 
at 37°C with gentle shaking and then washed twice 
with Medium H to remove Na’*‘I not taken up by 
the cells. About 6% of the *“I added was taken up 
and this could be reduced to less than 0.3% by 
addition of KC104 to low3 M. The cells were resus- 
pended in Medium H (8 X 1 O6 cells/ml) and 250 ~1 
aliquots immediately added to 250 ~1 of the same 
medium containing test material. During incubation 
at 37°C with shaking (1 SO cycleslmin) the tubes 
were briefly removed from the water bath and the 
total amount of 1251 in each reaction mixture deter- 
mined. The cells were then centrifuged at 1500 X g 
for 1 min and the amount of “‘1 in the cell pellet 
deterred. All determinations were made in triplicate. 
Results were expressed as the % lzsI released in the 
presence of test material minus the % “‘1 released 
in the presence of Medium H only or Medium H 
~ntaining appropriate control material. 
The effect of Graves’ immunoglobulins on the binding of 
‘2SI-TSH to isolated thyroid cells expressed 
as a (%) f SE 
Test material “‘1-TSH Bound (%) 
Medium only 1.2 f 0.1 
Normal immunoglobuiins (10 mg/mlf 1.0 f 0.0 
Graves’ immunogfobuliis (10 mg/ml) 
Ch 0.7 * o.oa 
wh 0.6 + O.lb 
Tu 0.7 + 0.1a 
Ca 0.6 i. O.lb 
aIndicates results significantly different from normal immuno- 
globulins at P = 0.05 and ‘+ at P = 0.01. 
2.4. Intracellular cycle AMP levels 
Isolated thyroid cells (8 X 106/ml} in 0.75 ml of 
Medium H were added to 0.75 ml of the same 
medium containing unlabelled bovine TSH and incub- 
ated with shaking at 37’C. After various times the 
mixtures (groups of 3 for each deter~nation) were 
centrifuged (1500 X g for 1 min) and the cell pellets 
suspended at 0°C in 250 ~1 of 10 mM theophylline. The 
suspensions were heated at 85°C for 10 min. cooled to 
0°C and centrifuged for 15 min at 1500 X g. 
Aliquots (2 X 50 ~1) were determined for cyclic AMP 
by a competitive protein binding method [ 131. 
Results were expressed as the amount of cyclic AMP 
produced in picomoles/2 X lo6 cells. 
of thyroid cells was bound by the cells in the absence 
of unlabelled TSH. Significant inhibition of ‘251-TSH 
binding was observed with the addition of as little as 
0.3 ng (10 PIJ) of unlabelled hormone. Labelled TSH 
binding was also inhibited by Graves’ immunoglobulins 
(table 1). Large doses of unlabelled TSH (3000 ng) 
reduced 1abelIed hormone binding to about 0.2% 
whereas similar amounts of ACTH or hCG reduced 
binding only slightly. The amount of label bound 
in the presence of 3000 ng of unlabelled hormone 
was taken as non-specific binding and all binding 
data were corrected for non-specific binding by this 
method. Labelled TSH binding to empty plastic 
tubes or plastic tubes containing mouse spleen lympho- 
cytes was about 0.1% and this was not significantly 
reduced in the presence of large doses of unlabelled 
TSH. Figure 1 shows the relations~p between the 
amount of TSH added to the cells and the amount 
of TSH bound (calculated by multiplying the total 
amount of hormone present by the fraction specifically 
bound). 
2.5. Preparation of immunoglobulins 
Immuno~obu~ns were precipitated from serum 
by addition of 3.75 M ammonium sulphate [1 l] , 
dialysed exhaustively against 150 mM NaCl followed 
by 20 vol. of Medium H (~thout calf serum) and 
stored at -25’C. 
Kinetics studies indicated that with a hormone 
concentration of 6.6 ng/ml and 4 X LO6 thyroid 
cells/ml, TSH binding was half m~imal at 2.5 min 
and maximal at 10 min (fig.2). Dissociation of bound 
labelled TSH was found to be half maximal at 4 min 
in the presence of excess (6 &ml) unlabelled TSH. 
3. Results 
3.1. Thyrotrophin receptor binding 
About 1% of the labelled TSH added to suspensions 
Scatchard analysis [14] of equilibrium binding 
data gave approximately linear plots. Two separate 
experiments gave association constants of 1.3 and 
1.8 X 10’ M-r. The mean m~mum TSH binding 
capacity of 2 X lo6 cells was 100 pg which represented 
about 1 O3 sites/cell. 
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I- r 3.2. Intracellular cyclic AMP levels 
0.03 0.3 3 
- 16 
_ 12 
tntracellular 
cyclic AMP 
(picomoles) 
- 6 
Unlaix?lled TSH added (ng) 
Fig.1. The relationship between TSH receptor binding (a), 
intracellular cyclic AMP levels (A) and “‘1 release (0) in 
isolated thyroid cells. Cell concentration 4 X 106/ml, 
reaction volume 0.5 ml, incubation time 10 min. Each 
point shown is a mean of closely agreeing triplicates. In the 
absence of unlabelled TSH (point 0 on TSH added axis) 
the amount of labelled hormone bound was 0.6 pg. In the 
presence of 0.1 ng of unlabelled TSH the amount of 
hormone bound (unlabelled + labelled) was 2 pg. The data 
were typical of several separate xperiments. 
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Fig.2. Kinetics of TSH receptor binding(o), changes in 
intracellular cyclic AMP levels (A), and ‘*‘I release (0) in 
isolated thyroid cells. Cell concentration 4 X lO’/ml, TSH 
concentration 6.6 ng/ml. Each point shows the mean of 
closely agreeing triplicates. The data were typical of several 
separate xperiments. 
Detectable increases in intracellular cyclic AMP 
levels were observed with as little as 0.3 ng of TSH 
(fIg.1). Half maximal increases were observed with 
10 ng of hormone and maximal increases with 
300 ng. Larger doses of TSH gave submaximal changes 
in cyclic AMP levels. Kinetic studies indicated that 
with 4 X 1 O6 cells/ml and a TSH concentration of 
6.6. &ml changes in cyclic AMP levels were unde- 
tectable at 2 min, maximal at 5 min and less than 
maximal at 10 min (fig.2). 
3.3. lz51 release 
Detectable stimulation of “‘1 release by the cells 
was observed with the addition of less than 0.3 ng 
of TSH (fig.1). Half maximal stimulation of “‘1 
release was observed with 1 ng of TSH and maximal 
stimulation with 3 ng. Analysis of the radioactive 
materials released from the cells by thin layer 
chromatography [ 151 indicated that about 90% of 
the 12’1 released was in the form of Na12’ I. Kinetic 
studies showed that with 4 X lo6 cells/ml and a 
hormone concentration of 6.6 ng/ml half maximal 
stimulation of “‘1 release occurred after less than 
2 min and maximal stimulation after 10 min (fig.2). 
Dibutyryl cyclic AMP stimulated “‘1 release from 
the isolated cells but somatostatin, ACTH and hCG 
were without significant effect (table 2). 
Iodine release was also stimulated to a small, 
but significant, extent by immunoglobulins from a 
pool of normal serum (table 2). The immunoglobulins 
from only 2 (patients Su and He) out of the 6 
Graves’ sera studied stimulated 12’1 release to an 
extent significantly greater than the normal pool. 
The effects of the active Graves’ immunoglobulins 
showed similar kinetics to those of TSH. 
4. Discussion 
The interaction between TSH and TSH receptors 
on isolated thyroid cells was characterized by rapid 
association and dissociation reactions. Scatchard 
analysis of equilibrium binding data suggested the 
presence of a single population of non-interacting 
TSH binding sites with an association constant of 
about 10’ M-' . These results were in good agreement 
with a recent report by Verrier et al. [9]. 
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Table 2 
Stimulation of iodine release from isolated thyroid cells 
Sample Concentration ‘*‘I Released (%) 
TSH 0.2 nM 20.1 f 0.9b 
20 nM 21.4 + O.gb 
Dibutyryl cyclic AMP 0.2 mM 1.9 t 0.9 
2 mM 14.2 f. O.gb 
ACTH 20 mM 2.1 +_ 1.0 
hCG 20 nM 2.4 f 1.1 
Somatostatin 350 nM 2.3 f 1.5 
700 nM 0.0 f 1.6 
Immunoglobulins 10 mg/ml 
Normal pool 3.3 * 0.7a 
Graves’ Ch -0.7 + 1.1 
Wh 1.4 f 0.9 
Tu 4.4 f 0.7b 
Ca 0.5 + 2.2 
su 10.9 + 1.9b 
He 7.1 f 1.4a 
The “‘1 released was expressed as the difference between means of samples 
containing medium only and samples containing test material f standard error 
of the difference. aIndicates significant release at P = 0.05 and bat P = 0.01. Only 
the immunoglobulins from patients Su and He stimulated lz51 release to an 
extent greater than the normal pool (P = 0.05). 
Several studies have indicated that the effects of 
TSH on the thyroid are mediated by cyclic AMP 
[ 1 ,161 and our observations that dibutyryl cyclic 
AMP was able to stimulate “‘1 release from isolated 
thyroid cells (table 2) was consistent with these 
earlier studies. Minimal detectable changes in receptor 
binding, intracellular cyclic AMP levels and 1251 release 
were observed with similar doses (about 0.3 ng) of TSH 
(fig.1). Although subsequent increases in intracellular 
cyclic AMP levels corresponded approximately with 
increases in receptor binding only small changes in 
these two systems corresponded with maximal stimula- 
tion of “‘1 release. 
The iodine released by the cells was mainly in 
the form of Na12’I indicating that little iodine 
organification had occurred. This was probably 
due to a lack of follicular structure in the porcine 
thyroid cell suspensions as such a structure has been 
shown to be necessary for extensive iodine organifica- 
tion in vitro [7]. Similarly, suspensions of bovine 
thyroid cells have been shown to organify only small 
amounts of iodine, particularly in the absence of TSH 
t171. 
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Kinetic studies indicated that 2 min after addition 
of TSH, stimulation of “‘1 release was greater than 
half maximal, receptor binding slightly less than half 
maximal and any changes in intracellular cyclic AMP 
levels undetectable. Consequently considerable TSH 
stimulation of 12’1 release occurred before any detect- 
able changes in intracellular cyclic AMP levels and this 
might have indicated that cyclic AMP was not involved 
in mediating the stimulation of iodine release. However, 
dibutyryl cyclic AMP was able to mimic the effects 
of TSH on 12’1 release and therefore, the data 
suggested that the effect of TSH on “‘1 release was 
mediated by cyclic AMP but that only small changes 
in cyclic AMP concentration were involved. 
Increases in intracellular cyclic AMP levels were 
consistently reduced by incubations longer than 
S-10 min (fig.2). This effect could possibly have 
involved stimulation of intracellular phosphodiesterase 
activity by TSH in a way analogous to the effects 
of insulin on fat cells [ 181. Prolonged incubation or 
large doses of TSH also resulted in a reduction in 
“‘1 release, but this was probably due to stimulation 
of the apparently slower process of “‘1 uptake. 
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Immunoglobulins from patients with Graves’ 
disease interacted with the TSH receptor on isolated 
thyroid cells in such a way as to inhibit labelled 
TSH binding (table 1). This observation was in good 
agreement with previous studies on the binding of 
Graves’ immunoglobulins and TSH to thyroid 
membranes [5,1 I] and isolated thyroid cells [19]. 
However the interaction between the antibody 
molecules and the isolated porcine thyroid cells 
did not appear to be particularly effective in causing 
cell stimulation as immunoglobulins from only 2 out 
of the 6 sera studied were capable of inducing 
significant stimulation of 12’1 release (table 2). 
Consequently the interaction of Graves’ immuno- 
globulins with the porcine TSH receptor does not 
always lead to cell stimulation. This phenomenon 
may be related to the partial phylogenetic specificity 
of the thyroid stimulating activity of Graves’ immuno- 
globulins originally described by Adams and Kennedy 
[20]. However, recently we have observed in a few 
patients with ophthalmic Graves’ disease the presence 
of antibodies which interact with the human TSH 
receptor but are unable to stimulate thyroid function 
[21] and this can be considered analogous to our 
observations with the porcine TSH receptor. 
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